Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity

Diabetologia
A L CareyB A Kingwell

Abstract

Brown adipose tissue (BAT) activation increases energy expenditure and may have therapeutic potential to combat obesity. The primary activating and adaptive signal for BAT is via β-adrenergic signalling. We previously demonstrated that human BAT is acutely responsive to oral administration of the sympathomimetic, ephedrine. Here we aimed to determine whether adaptive thermogenesis can be induced via chronic treatment with ephedrine. Twenty-three healthy young men, recruited from the general public in Melbourne, Australia, who were non-smokers, physically inactive and non-medicated with no prior history of cardiovascular disease or diabetes were recruited for this study. They were assigned to receive either 1.5 mg kg(-1) day(-1) ephedrine ('active' group; n = 12, age 23 ± 1 years, BMI 24 ± 1 kg/m(2)) or placebo (n = 11; 22 ± 2 years, 23 ± 2 kg/m(2)) for 28 days in a randomised (computer-generated random order sequence), placebo-controlled, parallel-group trial. Participants and all investigators were blinded to treatments. Body composition was measured before and after the intervention by dual energy X-ray absorptiometry. BAT activity, measured via (18)F-fluorodeoxyglucose positron emission tomography-computed tomography, in res...Continue Reading

References

Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·O ChampignyB R Holloway
Sep 22, 1995·The Journal of Biological Chemistry·R J RohlfsR Hille
May 29, 2000·Clinical Pharmacology and Therapeutics·S L SchiffelersM A van Baak
Mar 10, 2001·Recent Progress in Hormone Research·S Collins, R S Surwit
Jan 13, 2004·Physiological Reviews·Barbara Cannon, Jan Nedergaard
Apr 10, 2009·The New England Journal of Medicine·Wouter D van Marken LichtenbeltG J Jaap Teule
Apr 10, 2009·The New England Journal of Medicine·Aaron M CypessC Ronald Kahn
Apr 10, 2009·The New England Journal of Medicine·Kirsi A VirtanenPirjo Nuutila
May 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria Cristina ZingarettiSaverio Cinti
Nov 10, 2009·The Journal of Clinical Endocrinology and Metabolism·Monica C SkarulisPhillip Gorden
Jan 20, 2010·European Journal of Applied Physiology·Donny M CameraAndrew L Carey
Oct 12, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·B Cannon, J Nedergaard
Mar 11, 2011·PloS One·Guy H E J VijgenWouter D van Marken Lichtenbelt
Apr 15, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Wouter D van Marken Lichtenbelt, Patrick Schrauwen
Oct 28, 2011·The New England Journal of Medicine·Priya SumithranJoseph Proietto
Nov 18, 2011·The Journal of Clinical Endocrinology and Metabolism·Nora E StraznickyElisabeth A Lambert
Jan 25, 2012·The Journal of Clinical Investigation·Véronique OuelletAndré C Carpentier
Jun 1, 2012·Frontiers in Endocrinology·Otto MuzikJames G Granneman
Jun 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Aaron M CypessC Ronald Kahn
Oct 9, 2012·Antiviral Therapy·Martin TorrianiSteven Grinspoon
Oct 16, 2012·Diabetologia·A L CareyB A Kingwell
Nov 21, 2012·PloS One·Louis Z SharpShingo Kajimura
May 31, 2013·Pharmacology & Therapeutics·Andrew L Carey, Bronwyn A Kingwell
Jul 23, 2013·The Journal of Clinical Investigation·Takeshi YoneshiroMasayuki Saito
Jul 23, 2013·The Journal of Clinical Investigation·Anouk A J J van der LansWouter D van Marken Lichtenbelt
Sep 26, 2013·BMC Cell Biology·Maria MurholmJacob B Hansen
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Denis P BlondinFrançois Haman
Jan 28, 2014·Trends in Endocrinology and Metabolism : TEM·Wouter van Marken LichtenbeltLisje Schellen
May 3, 2014·PloS One·Hyung Sun YooJianhua Shao
May 30, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Anouk A J J van der LansWouter D van Marken Lichtenbelt
Jun 6, 2014·Annals of Medicine·Takeshi Yoneshiro, Masayuki Saito

❮ Previous
Next ❯

Citations

Jun 9, 2015·Diabetes·Matthias J Betz, Sven Enerbäck
Jul 5, 2017·Hormone Molecular Biology and Clinical Investigation·Baskaran Thyagarajan, Michelle T Foster
Jul 15, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·R K C LohA L Carey
Feb 10, 2016·Phytotherapy Research : PTR·Sidney J Stohs, Vladimir Badmaev
Apr 29, 2018·The Journal of Endocrinology·John-Paul Fuller-Jackson, Belinda A Henry
Sep 12, 2018·Diabetes, Obesity & Metabolism·Rebecca K C LohAndrew L Carey
Aug 19, 2016·The American Journal of Clinical Nutrition·Jens Bülow
Aug 12, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Hanbing LiLinghuan Li
Feb 20, 2021·Annals of the New York Academy of Sciences·Prasanna SanthanamRexford S Ahima
Feb 23, 2021·Frontiers in Neuroscience·Lachlan Van SchaikJoseph A Rathner
Jun 3, 2021·Pharmaceuticals·Carlos M Jimenez-MunozKamil Makowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.